NSCLC patients express more SNHG1 and RMRP in plasma than the control group (both p ≤ 0.05), and among the development cohort, compared with either gene alone, these two genes together have a diagnostic sensitivity of 84.13% for NSCLC, thereby improving the rate of diagnosis of NSCLC (Lin et al., 2018). The gene discussed is SNHG1; the disease is non-small cell lung carcinoma.